abstract |
The present invention comprises pH 3.0 comprising an antioxidant selected from the group consisting of epinephrine, sodium metabisulfite, sodium sulfite and sodium bisulfite, tartrate, osmotic pressure regulator, EDTA or Na 2 EDTA * 2H 2 O. For an injectable pharmaceutical composition of ~ 4.5. |